A post-hoc subgroup analysis of women at higher fracture risk showed that bazedoxifene 20mg reduced the incidence of non-vertebral fracture by 52% relative to placebo. With regard to
GlaxoSmithKline signed the deal with the Defense Threat Reduction Agency of the US Department of Defense, and said that it will provide supplemental staff and cover other program
The data was presented in late-breaking sessions at the Interscience Conference on Antimicrobial Agents and Chemotherapy meeting. This newly approved CCR5 antagonist – the first new class of
Ceftobiprole also was found to clinically cure more than 90% of patients who had infections caused by Staphylococcus aureus, including patients with complicated skin infections due to PVL-positive
The State of Maryland is contributing $100,000 of the $232,000 per year to the project at University of Maryland, Baltimore (UMB), with an agreement to provide second year
The two Phase III trials are anticipated to each enroll approximately 300 patients. AZ-004 is being developed through Symphony Allegro, a product development collaboration formed between Alexza and
Based on the recommendation of an independent data monitoring committee (IDMC), which conducted the planned interim, the control arm of the trial was stopped early to allow patients
Under the terms of the agreement, Evotec would issue, and Renovis shareholders would receive, American Depository Shares representing 1.0542 Evotec ordinary shares in exchange for each outstanding share
Saliva NicAlert results using saliva samples tested on-site closely matched those obtained by much more expensive and complex testing technology using urine samples sent off-site to an independent
According to the company, a second eight-day, exploratory study with Exubera and Lantus in patients with type 2 diabetes not controlled with multiple diabetes pills showed that daily
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.